People · Operator
Named in public records as an officer, director or promoter · active 2016–2021 · Biotechnology, Other, AI / ML, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Iterative Scopes, Inc. | — | Biotechnology | Series D+ | $172.1M | $3.6B | 2021 |
| Hatfield, Inc. | — | Other | Series B | $21.5M | $299.1M | 2018 |
| AI Fleet Inc. | — | AI / ML | Series B | $21.0M | $483.1M | 2021 |
| Zy Therapeutics Inc. | — | Pharmaceuticals | Series A | $6.0M | $185.8M | 2016 |
Nan Li at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Nan Li on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Neil Sequeira | 1 | 14 |
| PETER MORAN | 1 | 9 |
| Lonne Jaffe | 1 | 8 |
| Jun Li | 1 | 7 |
| Charles Cooney | 1 | 4 |
| Paul Huber | 1 | 3 |
| Avinash Anand | 1 | 1 |
| ZIYI WANG | 1 | 1 |
| JIAN BAO | 1 | 1 |
| YONGMING ZHANG | 1 | 1 |
| Jonathan Ng | 1 | 1 |
| Marc El Khoury | 1 | 1 |
| Gernot Zacke | 1 | 1 |
| Edward Chung | 1 | 1 |
| Gene Conley | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.